Attorneys for Ms. Holmes and Ramesh “Sunny” Balwani, former Theranos president and COO, reportedly cited the millions of pages of evidence and difficulties in recruiting high-profile witnesses as justification for the need for a delay in beginning the trial.
Judge Edward J. Davila reportedly discussed a potential April 2020 start for the trial but ruled not to make an official decision until July. The trial is expected to last at least 40 days.
Ms. Holmes and Mr. Balwani are facing 11 counts of felony fraud, stemming from what prosecutors say were misleading claims about Theranos’ blood testing technology. Prosecutors continue to investigate the pair and the now-defunct company but declined to state at Monday’s hearing whether they will be pursuing additional charges.
More articles about health IT:
Google’s AI-powered healthcare solutions require support from patients, academia, medical community
Washington State University settles $5.26M data breach class-action suit
U of California granted new CRISPR patent
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
